Abstract: A method includes reading data encoded on a tiny RFID tag that is embedded in an integrated circuit. The RFID tag has an area of 0.1 mm2 or less and, alternatively, of 0.05 mm2 or less. When the data satisfies predetermined criteria, a capability of a device or system is unlocked. The method may be used in conjunction with artificial intelligence (AI) for identification and authentication, fraud detection, behavioral analysis, predictive analytics, and/or access control, for example. The method may also be used in credit and/or debit card transactions, in which the tiny RFID tag and integrated circuit are on a credit and/or debit card. In another embodiment, the RFID tag and IC are incorporated into a label. The label may optionally be on a good for sale.

Abstract: A method of unlocking an operation of a Class III medical device suitable for use in treating, for example, COVID 19 in humans is presented. An integrated circuit is inserted or integrated into a medical device having an RFID reader, the medical device having a capability that is in a locked state. The integrated circuit has a first tiny RFID tag embedded therein. The RFID tag has an area of about 0.1 mm2 or less. The RFID tag is a largely digital tag that is implemented using portable digital IP blocks, the RFID tag utilizing dual-phase RF-only logic.

Abstract: The present invention provides compositions and methods for reducing microbial and nematodal contamination or infection in plants, animals, fabrics, and products therefrom. The present invention also provides compositions and methods for reducing human infections and the emergence of antimicrobial resistance. In particular, the invention provides magnetic nanoparticles comprising biocidal or biostatic enzymes in one component, substrates for the enzymes in a second component, and a biocidal chemical agent that works in combination or synergistically with the enzymes. The compositions are dormant and become active upon exposure to hydration, oxygen, or mixing.

Abstract: The present disclosure relates to an extruded industrial fabric. A method of manufacture of the industrial fabric is crosshead extruding a first layer polymeric matrix material with linear components. The linear components crosshead extruded with the polymeric matrix material may be continuous systems oriented in the machine direction. A nonwoven layer of material is provided on a surface of the first layer of polymeric matrix material and a second layer of polymeric matrix material is extruded onto the nonwoven layer of material. The first layer of polymeric matrix material at least partially encompasses the linear components. A faceside of the industrial fabric may be smooth or may include a texture or pattern. A backside may be smooth (planar), have a variable roughness, or include needled fibers that are incorporated into the structure of the fabric.

Abstract: The present disclosure may include a method of training an electro-mechanical system that includes local trainable AI, including training a local AI for a controller of the electro-mechanical system with simulated data. A task or set of tasks or operations with the device or system as controlled, instructed, influenced, or the like by the controller having the local AI system may be performed. Real-life data may be collected from the step of performing. Further training of the local AI system is done and improving the AI simulated data generator with real-life data. A chat function may provide a human ability to ask questions. In another aspect, a system for providing a user with suggestions during social interactions. The invention may extend across many combinations of devices and systems, control systems, sensors, types of AI, and so forth.

Abstract: The present invention provides compositions and methods for reducing microbial and nematodal contamination or infection in plants, animals, fabrics, and products therefrom. The present invention also provides compositions and methods for reducing human infections and the emergence of antimicrobial resistance. In particular, the invention provides magnetic nanoparticles comprising biocidal or biostatic enzymes in one component, substrates for the enzymes in a second component, and a biocidal chemical agent that works in combination or synergistically with the enzymes. The compositions are dormant and become active upon exposure to hydration, oxygen, or mixing.

Abstract: The present disclosure relates to a nonwoven extruded industrial fabric. A method of manufacture of the industrial fabric is crosshead extruding a polymeric matrix material with linear components. The linear components crosshead extruded with the polymeric matrix material may be continuous systems oriented in the machine direction. The polymeric resin matrix at least partially encompasses one or more of the linear components. The resin matrix may likewise be further reinforced by the inclusion of nanoparticles, nanomaterials, and/or chopped fibers. A faceside of the industrial belt may be smooth or may include a texture or pattern.

Abstract: The invention relates to an industrial fabric, such as a texturing belt, used to create three-dimensional structures in a product produced thereon, e.g., in the papermaking field, such as for fiber products, and in nonwoven processes. The invention concerns a texturing belt that can impart an endless variety of complex patterns utilizing discretization, such as, wherein individual subunits that comprise a pattern element are not connected, and therefore do not act as a stressed member of the texturing belt.

Abstract: A method includes reading data encoded on a tiny RFID tag that is embedded in an integrated circuit. The RFID tag has an area of 0.1 mm2 or less and, alternatively, of 0.05 mm2 or less. When the data satisfies predetermined criteria, a capability of a device or system is unlocked. The method may be used in conjunction with artificial intelligence (AI) for identification and authentication, fraud detection, behavioral analysis, predictive analytics, and/or access control, for example. The method may also be used in credit and/or debit card transactions, in which the tiny RFID tag and integrated circuit are on a credit and/or debit card. In another embodiment, the RFID tag and IC are incorporated into a label. The label may optionally be on a good for sale.

Abstract: A system includes a memory-mapped register (MMR) associated with a claim logic circuit, a claim field for the MMR, a first firewall for a first address region, and a second firewall for a second address region. The MMR is associated with an address in the first address region and an address in the second address region. The first firewall is configured to pass a first write request for an address in the first address region to the claim logic circuit associated with the MMR. The claim logic circuit associated with the MMR is configured to grant or deny the first write request based on the claim field for the MMR. Further, the second firewall is configured to receive a second write request for an address in the second address region and grant or deny the second write request based on a permission level associated with the second write request.

Abstract: \A method of unlocking an operation of a Class III medical device suitable for use in treating, for example, COVID 19 in humans is presented. An integrated circuit is inserted or integrated into a medical device having an RFID reader, the medical device having a capability that is in a locked state. The integrated circuit has a first tiny RFID tag embedded therein. The RFID tag has an area of about 0.1 mm2 or less. The RFID tag is a largely digital tag that is implemented using portable digital IP blocks, the RFID tag utilizing dual-phase RF-only logic.

Abstract: A method of unlocking an operation of a Class III medical device suitable for use in treating, for example, COVID 19 in humans is presented. An integrated circuit is inserted or integrated into a medical device having an RFID reader, the medical device having a capability that is in a locked state. The integrated circuit has a first tiny RFID tag embedded therein. The RFID tag has an area of about 0.1 mm2 or less. The RFID tag is a largely digital tag that is implemented using portable digital IP blocks, the RFID tag utilizing dual-phase RF-only logic.

Abstract: A method of unlocking an operation of a Class III medical device suitable for use in treating, for example, COVID 19 in humans is presented. An integrated circuit is inserted or integrated into a medical device having an RFID reader, the medical device having a capability that is in a locked state. The integrated circuit has a first tiny RFID tag embedded therein. The RFID tag has an area of about 0.1 mm2 or less. The RFID tag is a largely digital tag that is implemented using portable digital IP blocks, the RFID tag utilizing dual-phase RF-only logic.

Abstract: A system includes a memory-mapped register (MMR) associated with a claim logic circuit, a claim field for the MMR, a first firewall for a first address region, and a second firewall for a second address region. The MMR is associated with an address in the first address region and an address in the second address region. The first firewall is configured to pass a first write request for an address in the first address region to the claim logic circuit associated with the MMR. The claim logic circuit associated with the MMR is configured to grant or deny the first write request based on the claim field for the MMR. Further, the second firewall is configured to receive a second write request for an address in the second address region and grant or deny the second write request based on a permission level associated with the second write request.

Abstract: A system includes a memory-mapped register (MMR) associated with a claim logic circuit, a claim field for the MMR, a first firewall for a first address region, and a second firewall for a second address region. The MMR is associated with an address in the first address region and an address in the second address region. The first firewall is configured to pass a first write request for an address in the first address region to the claim logic circuit associated with the MMR. The claim logic circuit associated with the MMR is configured to grant or deny the first write request based on the claim field for the MMR. Further, the second firewall is configured to receive a second write request for an address in the second address region and grant or deny the second write request based on a permission level associated with the second write request.

Abstract: The present invention provides compositions and methods for reducing bacterial contamination or infection in plants, animals, fabrics, and products therefrom. The present invention also provides compositions and methods for reducing human infections and the emergence of antibiotic resistance. In particular, the invention provides magnetic nanoparticles comprising bactericidal or bacteriostatic enzymes in one component, substrates for the enzymes in a second component, and a bactericidal chemical agent that works in combination or synergistically with the enzymes. The compositions are dormant and become active upon exposure to hydration, oxygen, or mixing.

Abstract: A multilayer belt structure that can be used for creping or structuring a cellulosic web in a tissue making process. The multilayer belt structure allows for the formation of various shaped and sized openings in the top surface of the belt, while still providing a structure having the strength, durability, and flexibility required for tissue making processes.

Abstract: A system includes a memory-mapped register (MMR) associated with a claim logic circuit, a claim field for the MMR, a first firewall for a first address region, and a second firewall for a second address region. The MMR is associated with an address in the first address region and an address in the second address region. The first firewall is configured to pass a first write request for an address in the first address region to the claim logic circuit associated with the MMR. The claim logic circuit associated with the MMR is configured to grant or deny the first write request based on the claim field for the MMR. Further, the second firewall is configured to receive a second write request for an address in the second address region and grant or deny the second write request based on a permission level associated with the second write request.

Abstract: A multilayer belt structure that can be used for creping or structuring a cellulosic web in a tissue making process. The multilayer belt structure allows for the formation of various shaped and sized openings in the top surface of the belt, while still providing a structure having the strength, durability, and flexibility required for tissue making processes.

Abstract: A multilayer belt structure that can be used for creping or structuring a cellulosic web in a tissue making process. The multilayer belt structure allows for the formation of various shaped and sized openings in the top surface of the belt, while still providing a structure having the strength, durability, and flexibility required for tissue making processes.